AI Assistant
Blog
Pricing
Log In
Sign Up
Crizotinib in ROS1-positive non-small cell lung cancer: an Asian large phase II trial confirms its key-role
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
